Skip to main content
Application L2411

Combining Real-Time Monitoring Using Raman Spectroscopy, Rotating-Bed Reactors, and Green Solvents to Improve Sustainability in Solid-Phase Peptide Synthesis

Eugenie Fournier, Arjun Vijeta, Oleg Babii, Mohamad-Jamal Wawi, Bernd Henkel, Hélène Adihou

ACS Sustainable Chem. Eng., 2024, 12 (38), pp. 14260-14271

"In response to the need for more sustainable practices in peptide synthesis, particularly in the context of solid-phase peptide synthesis (SPPS), this study introduces a transformative approach toward achieving sustainability. This work combines, for the first time, the use of Raman spectroscopy as a process analytical tool (PAT) for real-time monitoring and optimization of reaction steps and substitution of environmentally concerning N,N-dimethylformamide (DMF) with a green solvent mixture of dimethyl sulfoxide (DMSO) and ethyl acetate (EtOAc). Assuming that in SPPS, the synthetic intermediates are not isolated, the utilization of PAT provides robust and high-resolution analytics to enable precise control of reaction end points, which allows for timely adjustments, leading to accelerated development, reduction of waste generation, and enhanced reaction efficiency. Additionally, SpinChem, a unique design of a rotating bed reactor, is introduced as an alternative reactor, which also enables easy integration of PATs to perform solid-phase synthesis. This study provides valuable insights and practical strategies to advance sustainable peptide synthesis, offering promising solutions for a greener future in the pharmaceutical industry."

L2411 Peptides synthesized in this study: Aib-Enkephalin and Gonadorelin

 

Highlights:

  • This study demonstrates a significant advancement in sustainable solid-phase peptide synthesis by integrating three key innovations: Raman spectroscopy for real-time process monitoring, SpinChem's rotating bed reactor for improved mass transfer, and environmentally friendly solvent systems replacing DMF.
  • The research team successfully synthesized two model peptides (Aib-enkephalin and gonadorelin) while achieving a 33% reduction in process mass intensity compared to conventional methods. This reduces the waste by more than one tonne per kg of product!
  • The SpinChem RBR's unique design enabled seamless integration of process analytical technology, providing precise reaction control and eliminating the need for intermediate isolation steps. This combination delivered enhanced peptide purity, reduced waste generation, and accelerated development timelines, establishing a practical pathway toward greener pharmaceutical manufacturing.

 

Authors & Research Group:

Institution: EUROAPI, Chemical Sciences & Data Department, research focus on sustainable peptide synthesis, process analytical technology, green chemistry, and pharmaceutical manufacturing optimization

Principal Investigator: Hélène Adihou, Ph.D. – Group Leader

Research Team:

Eugenie Fournier, LinkedIn

Arjun Vijeta 

Oleg Babii,  LinkedIn

Mohamad-Jamal Wawi, LinkedIn

Bernd Henkel, LinkedIn

SpinChem Commentary
Erik Löfgren CTO SpinChem

Erik Löfgren

Chief Technology Officer

erik@spinchem.com

RBR technology delivers measurable sustainability gains for pharmaceutical peptide synthesis

This research demonstrates how SpinChem RBR technology delivers practical sustainability improvements across pharmaceutical peptide synthesis. The 33% reduction in process mass intensity achieved by EUROAPI represents the kind of measurable resource efficiency that regulatory pressures and environmental commitments increasingly demand from pharmaceutical manufacturers. Beyond peptide synthesis, the capacity of the RBR to integrate process analytical technology positions it as a valuable tool for any solid-phase synthesis application where real-time monitoring can optimize reaction endpoints and reduce waste.

Meeting industry demands: sustainability without compromising quality

The pharmaceutical industry faces mounting pressure to reduce solvent consumption, minimize hazardous reagents, and improve process efficiency without compromising product quality. This study validates the RBR as an enabling technology for sustainable chemistry initiatives, offering pharmaceutical R&D teams a path to meet these requirements while maintaining the precision and reproducibility required for API production. The centrifugal flow design that enables seamless PAT integration also supports applications in specialty chemicals and biocatalysis where process optimization and data-rich experimentation drive competitive advantage.